Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Itacitinib for Thrombocythemia
Recruiting1 awardPhase 2
Spring, Texas
This trial has two parts. In the first, participants will be given different doses of the study drug to find the best dose (RP2D). In the second part, everyone will get the RP2D.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.